Beyond CD19 CAR-T cells in lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Beyond CD19 CAR-T cells in lymphoma

Published:2022-02 Issue: Volume:74 Page:46-52
ISSN:0952-7915
Container-title:Current Opinion in Immunology
language:en
Short-container-title:Current Opinion in Immunology

Author:

Leung Wingchi K,Ayanambakkam Adanma,Heslop Helen E^ORCID,Hill LaQuisa C

Funder

National Cancer Institute

CPRIT

Leukemia & Lymphoma Society

Cancer Research Trust New Zealand

Haematology Society of Australia and New Zealand

American Association for Cancer Research

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference54 articles.

1. CAR T-cell therapy for B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemia: clinical trials and real-world experiences;Vitale;Front Oncol,2020

2. Diagnostic, prognostic and therapeutic role of CD30 in lymphoma;Pierce;Expert Rev Hematol,2017

3. Understanding CD30 biology and therapeutic targeting: a historical perspective providing insight into future directions;van der Weyden;Blood Cancer J,2017

4. Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas;Younes;N Engl J Med,2010

5. Evaluation of the risk of relapse in classical Hodgkin lymphoma at event-free survival time points and survival comparison with the general population in British Columbia;Hapgood;J Clin Oncol,2016

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacotherapy of autoimmune rheumatic diseases – from monoclonal antibodies to CAR T cells: 20 years later;Rheumatology Science and Practice;2024-06-26

2. Potential and pitfalls of repurposing the CAR-T cell regimen for the treatment of autoimmune disease;Annals of the Rheumatic Diseases;2024-04-18

3. A dual-luciferase bioluminescence system for the assessment of cellular therapies;Molecular Therapy: Oncology;2024-03

4. Anti-CD79b/CD3 bispecific antibody combined with CAR19-T cells for B-cell lymphoma treatment;Cancer Immunology, Immunotherapy;2023-09-14

5. A Bibliometric and Knowledge-Map Analysis of CAR-T Cells From 2009 to 2021;Frontiers in Immunology;2022-03-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3